Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.46 |
| ▸ | NQO2 | P16083 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30828566 | 0.83 | MAPT (0.52) | APPALDH1A1KDM4EUSP2CYP19A1 | |
| SCHEMBL224141 | 0.83 | MAPT (0.52) | APPALDH1A1KDM4EUSP2CYP19A1 | |
| Hydrochloric Acid SCHEMBL30828603 | 0.82 | MAPT (0.50) | APPALDH1A1KDM4EUSP2CYP19A1 | |
| SCHEMBL6605467 | 0.80 | ALDH1A1 (0.46) | ALDH1A1KDM4EUSP2CYP19A1MAPT | |
| SCHEMBL21672910 | 0.80 | ALDH1A1 (0.42) | APPALDH1A1KDM4EUSP2CYP19A1 | |
| SCHEMBL19381538 | 0.80 | GAA (0.41) | APPALDH1A1KDM4EUSP2CYP19A1 | |
| SCHEMBL1413112 | 0.79 | GAA (0.51) | APPALDH1A1KDM4EUSP2CYP19A1 | |
| SCHEMBL15928734 | 0.79 | KDM4E (0.56) | APPALDH1A1KDM4EUSP2MAPT | |
| SCHEMBL18147051 | 0.78 | ALDH1A1 (0.51) | ALDH1A1KDM4EUSP2CYP19A1MAPT | |
| SCHEMBL7402548 | 0.78 | MAPT (0.44) | APPALDH1A1KDM4EUSP2CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024030651-A1 | GPX4 INHIBITORS AND USE THEREOF | SONATA THERAPEUTICS, INC. (US) | 2024-02-08 | — | — | WO | disclosed |
| EP-2828339-B1 | CARBOXYLATE DYES | MILLIKEN & CO (US) | 2018-10-31 | — | — | EP | disclosed |
| US-9187717-B2 | Carboxylate dyes | MILLIKEN & COMPANY (US) | 2015-11-17 | — | — | US | disclosed |
| US-20150099869-A1 | Carboxylate Dyes | MILLIKEN & COMPANY | 2015-04-09 | — | — | US | disclosed |
| EP-2828340-A1 | LAUNDRY CARE COMPOSITIONS CONTAINING DYES | The Procter & Gamble Company (US) | 2015-01-28 | — | — | EP | disclosed |
| EP-2828339-A1 | CARBOXYLATE DYES | Milliken & Company (US) | 2015-01-28 | — | — | EP | disclosed |
| WO-2014118092-A2 | DYE COMPOSITION COMPRISING AT LEAST ONE PARTICULAR LIPOPHILIC META-PHENYLENEDIAMINE COUPLER IN A MEDIUM RICH IN FATTY SUBSTANCES, PROCESSES AND DEVICES | L'OREAL (FR) | 2014-08-07 | — | — | WO | disclosed |
| WO-2013142495-A1 | CARBOXYLATE DYES | MILLIKEN & COMPANY (US) | 2013-09-26 | — | — | WO | disclosed |
| WO-2013142486-A1 | LAUNDRY CARE COMPOSITIONS CONTAINING DYES | THE PROCTER & GAMBLE COMPANY (US) | 2013-09-26 | — | — | WO | disclosed |
| EP-2406234-A1 | THIAZOLE SULFONAMIDE AND OXAZOLE SULFONAMIDE KINASE INHIBITORS | GlaxoSmithKline LLC (US) | 2012-01-18 | — | — | EP | disclosed |
| US-20110319392-A1 | Thiazole Sulfonamide And Oxazole Sulfonamide Kinase Inhibitors | GLAXOSMITHKLINE LLC | 2011-12-29 | — | — | US | disclosed |
| US-20110098296-A1 | Thiazole And Oxazole Kinase Inhibitors | GLAXOSMITHKLINE LLC | 2011-04-28 | — | — | US | disclosed |
| EP-2231625-A1 | THIAZOLE AND OXAZOLE KINASE INHIBITORS | GlaxoSmithKline LLC (US) | 2010-09-29 | — | — | EP | disclosed |
| WO-2010104899-A1 | THIAZOLE SULFONAMIDE AND OXAZOLE SULFONAMIDE KINASE INHIBITORS | GLAXOSMITHKLINE LLC (US) | 2010-09-16 | — | — | WO | disclosed |
| WO-2009076140-A1 | THIAZOLE AND OXAZOLE KINASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2009-06-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110098296-A1 | Thiazole And Oxazole Kinase Inhibitors | PDXK, MAP3K1, MAP4K2 | APP 4325/4885ALDH1A1 3014/4885KDM4E 1783/4885 |
| US-20110319392-A1 | Thiazole Sulfonamide And Oxazole Sulfonamide Kinase Inhibitors | STK24, MAP3K5, MAP3K2 | APP 4239/4885ALDH1A1 2613/4885KDM4E 1987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.